Clinical Trial Update: Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab [Phase 3]

View source ↗

Summary

A Phase 3b study evaluating tezepelumab in patients with severe asthma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezspire (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Asthma | Phase 3 | Status: RECRUITING